Logo3 26

INTERNATIONAL SYMPOSIUM OF CARDIOVASCULAR IMAGING

DIC 2021

An Imaging Tour Around The World

Patrocinadores

Assets Curso Dic-08
Assets Curso Dic-09
Assets Curso Dic-10

Escolha sua sala e aproveite o conteúdo

Programação

SALA 1

09:00 – SESSION 1 – New Developments in the evaluation of ventricular function

Old Stuff – M Mode, Tei index, MAPSE and S wave – does it adds anything to the clinical picture?

Speaker: Ricardo Ronderos

LVEF with or without myocardial oppacification. What should I do?

Speaker: Thomas Porter

LV Longitudinal Strain: clinical value in different scenarios.

Speaker: Victoria Delgado

RV and LV Longitudinal Strain: technical pitfalls and clinical value.

Speaker: Denisa Muraru

LA Longitudinal Strain: technical pitfalls and clinical value.

Speaker: Matteo Cameli

Thansthoracic 3D echo: What is it’s additional value over traditional methods for the evaluation of LV Function?

Speaker: Luigi Badano

Echo In SARS CoV2: What shall we look for?

Speaker: Bijoy K. Khandheria

13:00 – SESSION 2 – Interventional Echocardiography

RASHKIND: Do we still need echo in order to perfom it?

Speaker: Victor Guerra

PFO and ASD: technical pitfalls for the begginer.

Speaker: Ricardo Pignatelli

TAVI: Technical pitfalls of minimalist aproach.

Speaker: Bernard Cosyns

Advantages of using TEE during TAVI

Speaker: Victoria Delgado

Valve in valve: What are the parameters and complications I should look for?

Speaker: Judd Hung

MITRA-FR and COAPT: lessons from winning and failing

Speaker: Federico Asch

Percutaneous tricuspid interventions: present and future.

Speaker: Rebecca Hahn

16:50 – SESSION 3 – Heart Valve Disease for Everyday Practice

Mitral Valve Prolapse or MV Billowing: What are the criteria and how should I properly and easily name it?

Speaker: Denisa Muraru

Mitral valve prolapse in the octagenarian: When to intervene?

Speaker: Maurice Sarano

Mitral regurgitation: to quantify of not quantify: That is the question.

Speaker: Maurice Sarano

Aortic Stenosis with normal flow: How to determine the best timing for intervention.

Speaker: Juan Carlo Plana

Low Flow Low Gradient Aortic Stenosis with Preserved LVEF: How to determine the best timing for intervention.

Speaker: Philippe Pibarot

Low Flow Low Gradient Aortic Stenosis with Depressed LVEF: How to determine the individuals at the highest risk.

Speaker: Vera Rigollin

Tricuspid regurgitation: Step by step aproaches for determination of mechanism, severity and impact on RV function and Cardiac output.

Speaker: Roberto Lang

SALA 2

09:00 – SESSION 1 – Challenging Imaging in 2021 in Late-Postoperative of Congenital Heart Disease

Transposition of great Arteries

Speaker: Vitor Guerra

Tetralogy of Fallot

Speaker: Laura M Mercer-Rosa

10:40 – SESSION 2 – Vascular Ultrasound Update

Update – ASE Recommendations for the Assessment of Carotid Arterial Plaque by US

Speaker: Amer M.Johri

Applicability of ASE Recommendations

Speaker: Joseph Polak

Update – Interpretation of Peripheral Arterial Doppler waveforms and clinical implication of new terminology

Speaker: Esther S.H.Kim

12:10 – SESSION 3 – Hot Topics in Nuclear Cardiology Around the World

How does Ischemia trial changes my practice?

Speaker: Randall C. Thompson

Best use of myocardial perfusion imaging in patients with suspect or known chronic coronary syndrome

Speaker: Robert C Hendel

Myocardial Flow Reserve with CZT – are we ready?

Speaker: Terence Ruddy

How is pyriphosphate scan amyloidosis is rewriting the epidemiology of a disease

Speaker: Sharmila Dorbala

PET in infectious e inflammatory diseases

Speaker: Panithaya Chareonthaitawee

14:10 – SESSION 4 – Hot topics in CMR around the world

Why CMR in Cardiac Amyloidosis?

Speaker: Marianna Fontana

CMR for valvopathies: What can it add to Echocardiogram?

Speaker: Bernard Guerber

CMR: What do arrhythmologists should know?

Speaker: Karen Ordovas

Positive troponin with normal coronary arteries: The role of CMR.

Speaker: Chiara Bucciarelli-Ducci

Why do we still need Myocardial Delayed Enhancement on the era of T1 Mapping?

Speaker: Han Kim

16:40 – SESSION 5 – Coronary Computed Tomography Dilemas Around The World

CCTA as the first test for patients with suspected CAD

Speaker: Armin Zadeh

Is asymptomatic patients screening the next step for CCTA?

Speaker: Michelle Williams

Where AI can help us on CCTA evaluation in 2021 (plaque analysis, FFR-CT and more)

Speaker: Pál Maurovich-Horvat

CT role in the follow up of percutaneous structural procedures

Speaker: João Cavaltante

Top 10 CCTA papers in 2020

Speaker: Todd Villines 

19:10 – CLOSING SESSION

Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease

Speaker: Marcelo Di Carli 

Ultra-high resolution CT; the next frontier

Speaker: João A.C. Lima 

fale com a gente

Nosso suporte está sempre à disposição para ajudar.

[makadu_support_whats bg_color="#31BA46" radius="35" responsavel="kati"]

telefone: (51) 9 8224-0067

Shopping Cart